Financials
- Market Capitalization 13.14 M
- Employee 24
- Founded 2003
- CEO Philip A. Serlin
- Website www.biolinerx.com
- Headquarter Israel
- FIGI BBG001Y26LK0
- Industry 生物工学
総売上高
当期純利益
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4729 | QNCX Quince Therapeutics, Inc. - Common Stock | 17.94 USD | +4.00% | +8.14% | +1829.03% | +891.16% | 14.62 M USD | ||
| 4741 | PASG Passage Bio, Inc. - Common Stock | 4.32 USD | -3.14% | -13.25% | -24.08% | -51.13% | 13.86 M USD | ||
| 4751 | INTS Intensity Therapeutics, Inc. - Common Stock | 4.84 USD | -1.63% | 0.00% | +32.24% | +1366.67% | 13.08 M USD | ||
| 4752 | COCP Cocrystal Pharma, Inc. - Common Stock | 0.96 USD | 0.00% | -5.88% | -3.03% | -44.19% | 13.24 M USD |